NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Applovin
APP
US Stock MarketDetailed Quotes
GOSS Gossamer Bio
- 1.300
- +0.040+3.17%
Close Feb 26 16:00 ET
- 1.350
- +0.050+3.84%
Post 19:54 ET
294.59MMarket Cap-5.20P/E (TTM)
1.340High1.231Low1.68MVolume1.280Open1.260Pre Close2.17MTurnover0.92%Turnover RatioLossP/E (Static)226.60MShares1.60052wk High5.44P/B237.97MFloat Cap0.49952wk Low--Dividend TTM183.05MShs Float27.150Historical High--Div YieldTTM8.67%Amplitude0.453Historical Low1.293Avg Price1Lot Size
Gossamer Bio News
Is Gossamer Bio (NASDAQ:GOSS) Weighed On By Its Debt Load?
Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges
Gossamer Bio's Strategic Focus on PAH Unmet Needs and Seralutinib Efficacy Drives Buy Rating
12 Health Care Stocks Moving In Thursday's Pre-Market Session
After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
Gossamer Bio (GOSS) Gets a Buy From Oppenheimer
Express News | HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target
Gossamer Bio Analyst Ratings
Promising Progress and Expansion Potential of Gossamer Bio's Seralutinib Drive Buy Rating
Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets
Gossamer Bio Reports Revenue Growth Amid Strategic Collaborations
Gossamer Bio: Q3 Earnings Snapshot
Earnings Flash (GOSS) GOSSAMER BIO Reports Q3 Revenue $9.5M
Gossamer Bio | 10-Q: Q3 2024 Earnings Report
Gossamer Bio | 8-K: Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
Gossamer Bio 3Q Loss/Shr 14c >GOSS
Express News | Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
Express News | Gossamer Bio Q3 Operating Expenses USD 43.399 Million
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)